Stock 300878 ZHEJIANG WECOME PHARMACEUTICAL COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Zhejiang Wecome Pharmaceutical Company Limited

Equities

300878

CNE1000047P9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 17/05/2024 am IST 		5-day change 1st Jan Change
18.2 CNY +0.05% Intraday chart for Zhejiang Wecome Pharmaceutical Company Limited -2.36% -28.26%
28/04 Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
19/04 Zhejiang Wecome Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Zhejiang Wecome Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, production and sales of modern Chinese medicine and western medicine. The Company's main products include Yinhuang dripping pills, motherwort soft capsules, motherwort dispersible tablets, Guci capsules, Fengliao Changweikang dispersible tablets, ginseng Jianpi tablets and other Chinese patent medicines, as well as western medicines such as roxithromycin soft capsules. Its production dosage forms cover hard capsules, tablets, granules, soft capsules, and pills. The Company mainly conducts its businesses in the China market.

Number of employees: 1,082

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chinese and Western Patent Medicines
66.5 %
453 85.3 % 346 66.5 % -23.73%
Chinese Herbal Medicine
19.4 %
29 5.4 % 101 19.4 % +251.72%
Other
7.7 %
25 4.6 % 40 7.7 % +62.10%
Health Food
3.9 %
14 2.6 % 20 3.9 % +46.29%
Medical Instruments
1.6 %
8 1.5 % 8 1.6 % +0.11%
Other Business
1.0 %
3 0.6 % 5 1.0 % +67.09%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
531 100.0 % 520 100.0 % -2.20%

Managers

Managers TitleAgeSince
Xiao Xia Kong CEO
 Chief Executive Officer 42 17/21/17
Jing Wang DFI
 Director of Finance/CFO 37 17/21/17
Ting Zhu BRD
 Director/Board Member 35 17/21/17
Jian Ming Wu BRD
 Director/Board Member 58 26/18/26
Cai Hong Shen BRD
 Director/Board Member 42 26/15/26
Xiao Hong Yu
49 -
Si Wang IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Bin Wu BRD
 Director/Board Member 64 10/22/10
Jiang Feng Liu BRD
 Director/Board Member 45 17/21/17
Lan Hao BRD
 Director/Board Member 56 17/21/17
Zhong Liang Liu CHM
 Chairman 63 26/15/26
Ping Ye CHM
 Chairman 42 26/15/26
Xiao Hong Yu BRD
 Director/Board Member 49 01/00/01
Cai Hong Shen BRD
 Director/Board Member 42 26/15/26
Xiao Xia Kong CEO
 Chief Executive Officer 42 17/21/17
Jian Ming Wu BRD
 Director/Board Member 58 26/18/26
Ting Zhu BRD
 Director/Board Member 35 17/21/17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 144,790,322 36,125,312 ( 24.95 %) 0 24.95 %

Shareholders

NameEquities%Valuation
Golden Trust Sinopac Fund Management Co., Ltd.
1.230 %
489,709 1.230 % 1 M ¥
Essence Fund Co., Ltd.
1.148 %
457,400 1.148 % 1 M ¥
Western Leadbank Fund Management Co., Ltd
0.4017 %
160,000 0.4017 % 391 522 ¥
Wanjia Asset Management Co., Ltd.
0.2056 %
81,900 0.2056 % 200 410 ¥
Penghua Fund Management Co., Ltd.
0.2051 %
81,680 0.2051 % 199 872 ¥
China Southern Asset Management Co., Ltd.
0.0565 %
22,502 0.0565 % 55 063 ¥
Huatai-PineBridge Fund Management Co., Ltd.
0.0345 %
13,740 0.0345 % 33 622 ¥
Sealand Securities Co., Ltd. (Investment Management)
0.0281 %
11,200 0.0281 % 27 407 ¥
Yinhua Fund Management Co., Ltd.
0.0163 %
6,500 0.0163 % 15 906 ¥
HFT Investment Management Co., Ltd.
0.0146 %
5,800 0.0146 % 14 193 ¥

Company contact information

Zhejiang Wecome Pharmaceutical Co., Ltd.

2 Suisong Road Lishui Economic Development Zone

323000, Lishui

+

http://www.zjwk.com
address Zhejiang Wecome Pharmaceutical Company Limited(300878)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHEJIANG WECOME PHARMACEUTICAL COMPANY LIMITED Stock Zhejiang Wecome Pharmaceutical Company Limited
-28.26% 36Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 69TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 58TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 37TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+7.39% 29TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 24TCr
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 21TCr
NOVARTIS AG Stock Novartis AG
+10.02% 21TCr
AMGEN INC. Stock Amgen Inc.
+8.49% 17TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300878 Stock
  4. Company Zhejiang Wecome Pharmaceutical Company Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW